ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Baldness breakthrough? new pill promises hair regrowth in men
Disease control Not yet recruitingThis study tests an oral medication called N1087 (minoxidil) for male pattern hair loss. About 372 men aged 18 to 60 with moderate balding will take either the drug or a placebo daily for 24 weeks. The goal is to see if the pill increases hair density and is safe to use.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 14:00 UTC
-
One-shot hair fix? new study pits nanofat against daily creams
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat tissue) can outperform either PRP injections or daily minoxidil 5% for treating male and female pattern baldness. Sixty adults aged 18-50 with confirmed androgenetic alopecia will be enrolled. The goal is to se…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
Amniotic fluid injection could be new hope for baldness
Disease control Not yet recruitingThis study tests whether an experimental product called XVIE, made from processed human amniotic fluid, is safe and may help regrow hair in 30 adults with common pattern baldness. Participants receive either XVIE or a placebo injected into the scalp twice, 90 days apart, and are …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Restore Biologics Holdings, Inc. dba Xtressé • Aim: Disease control
Last updated May 17, 2026 13:57 UTC
-
Can lasers and stem cell juice regrow hair? new trial aims to find out
Disease control Not yet recruitingThis study tests whether combining a fractional laser treatment with a topical exosome solution (derived from stem cells) can improve hair regrowth in men with male pattern baldness. Thirty men aged 18 to 50 with moderate hair loss will receive three laser sessions, with half the…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hair loss drug combo enters human trials
Disease control Not yet recruitingThis early-stage trial tests a topical gel (AD-303A) and an oral pill (AD-3031) in 30 men aged 19–55 with male pattern baldness. The goal is to see how the drug moves through the body and if it is safe. The study is not yet recruiting and will help choose the right dose for futur…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Moogene Medi Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
AI set to revolutionize hair loss diagnosis
Diagnosis Not yet recruitingThis study aims to train and test artificial intelligence (AI) models to diagnose male and female pattern hair loss (androgenetic alopecia) and assess its severity. Researchers will use images from a handheld dermoscope along with patient age and sex to teach the AI to tell the d…
Matched conditions: ANDROGENETIC ALOPECIA
Sponsor: Cairo University • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC